Cargando…

Vaccines Produced by Conventional Means to Control Major Infectious Diseases of Man and Animals

This chapter reviews the development of some of vaccines and their use in controlling such major diseases as diphtheria, rinderpest, Newcastle disease, smallpox, pertussis, yellow fever, rabies, etc. Park–Williams Number 8 (PW8) strain is used to make diphtherial toxoid for vaccines. As a source of...

Descripción completa

Detalles Bibliográficos
Autores principales: BITTLE, JAMES L., MUIR, SUSIE
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ACADEMIC PRESS, INC. Published by Elsevier B.V. 1989
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150235/
https://www.ncbi.nlm.nih.gov/pubmed/2648772
http://dx.doi.org/10.1016/B978-0-12-039233-9.50005-6
_version_ 1783520984844730368
author BITTLE, JAMES L.
MUIR, SUSIE
author_facet BITTLE, JAMES L.
MUIR, SUSIE
author_sort BITTLE, JAMES L.
collection PubMed
description This chapter reviews the development of some of vaccines and their use in controlling such major diseases as diphtheria, rinderpest, Newcastle disease, smallpox, pertussis, yellow fever, rabies, etc. Park–Williams Number 8 (PW8) strain is used to make diphtherial toxoid for vaccines. As a source of toxin, it is rendered nontoxic by incubation with formalin under alkaline conditions. The product's retention of antigenicity, enabling it to induce antitoxin antibodies, makes it an excellent pediatric vaccine. Vaccine against Rinderpest Virus was developed by Koch in 1897 by administering bile from infected cattle. Animals that survived were permanently immune. Formalin- and chloroform-inactivated vaccines were developed using tissues from the infected animals. For the control of Newcastle disease, a number of attenuated live-virus vaccines have been developed which are widely used to control the disease. The Bl strain, the LaSota strain, and the F strain are used to immunize birds of all ages by different routes, including by addition to drinking water and by spraying. Protection against rabies correlates with SN antibody, which can be assessed by a number of tests. Pasteur's classical vaccine, developed from infected spinal cord tissue dried at room temperature for 3–14 days, was given in a series of 21–28 inoculations beginning with material dried the longest and progressing through material dried for only 3 days.
format Online
Article
Text
id pubmed-7150235
institution National Center for Biotechnology Information
language English
publishDate 1989
publisher ACADEMIC PRESS, INC. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71502352020-04-13 Vaccines Produced by Conventional Means to Control Major Infectious Diseases of Man and Animals BITTLE, JAMES L. MUIR, SUSIE Adv Vet Sci Comp Med Article This chapter reviews the development of some of vaccines and their use in controlling such major diseases as diphtheria, rinderpest, Newcastle disease, smallpox, pertussis, yellow fever, rabies, etc. Park–Williams Number 8 (PW8) strain is used to make diphtherial toxoid for vaccines. As a source of toxin, it is rendered nontoxic by incubation with formalin under alkaline conditions. The product's retention of antigenicity, enabling it to induce antitoxin antibodies, makes it an excellent pediatric vaccine. Vaccine against Rinderpest Virus was developed by Koch in 1897 by administering bile from infected cattle. Animals that survived were permanently immune. Formalin- and chloroform-inactivated vaccines were developed using tissues from the infected animals. For the control of Newcastle disease, a number of attenuated live-virus vaccines have been developed which are widely used to control the disease. The Bl strain, the LaSota strain, and the F strain are used to immunize birds of all ages by different routes, including by addition to drinking water and by spraying. Protection against rabies correlates with SN antibody, which can be assessed by a number of tests. Pasteur's classical vaccine, developed from infected spinal cord tissue dried at room temperature for 3–14 days, was given in a series of 21–28 inoculations beginning with material dried the longest and progressing through material dried for only 3 days. ACADEMIC PRESS, INC. Published by Elsevier B.V. 1989 2014-07-07 /pmc/articles/PMC7150235/ /pubmed/2648772 http://dx.doi.org/10.1016/B978-0-12-039233-9.50005-6 Text en Copyright © 1989 ACADEMIC PRESS, INC. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
BITTLE, JAMES L.
MUIR, SUSIE
Vaccines Produced by Conventional Means to Control Major Infectious Diseases of Man and Animals
title Vaccines Produced by Conventional Means to Control Major Infectious Diseases of Man and Animals
title_full Vaccines Produced by Conventional Means to Control Major Infectious Diseases of Man and Animals
title_fullStr Vaccines Produced by Conventional Means to Control Major Infectious Diseases of Man and Animals
title_full_unstemmed Vaccines Produced by Conventional Means to Control Major Infectious Diseases of Man and Animals
title_short Vaccines Produced by Conventional Means to Control Major Infectious Diseases of Man and Animals
title_sort vaccines produced by conventional means to control major infectious diseases of man and animals
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150235/
https://www.ncbi.nlm.nih.gov/pubmed/2648772
http://dx.doi.org/10.1016/B978-0-12-039233-9.50005-6
work_keys_str_mv AT bittlejamesl vaccinesproducedbyconventionalmeanstocontrolmajorinfectiousdiseasesofmanandanimals
AT muirsusie vaccinesproducedbyconventionalmeanstocontrolmajorinfectiousdiseasesofmanandanimals